In this article we are going to talk about Buthalital, a topic that has captured the attention of people of all ages and interests. Buthalital is a topic that has generated a lot of debate and controversy in recent times, and it is important to analyze it from different perspectives. From its impact on society to its relevance in popular culture, Buthalital has proven to be a topic of general interest that deserves to be explored in depth. Throughout this article, we will analyze different aspects of Buthalital, from its origin to its possible consequences in the future.
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C11H15N2NaO2S |
| Molar mass | 262.30 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Buthalital sodium (INN; Bayinal, Baytinal, Thialbutal, Transithal, Ulbreval), or buthalitone sodium (BAN), is a barbiturate derivative which was under development as a short-acting anesthetic.[1][2] However, development was discontinued, perhaps due to its extremely rapid elimination rate,[3] and buthalital sodium was never marketed.[1]